» Articles » PMID: 37568342

Cystic Parathyroid Adenomas As a Risk Factor for Severe Hypercalcemia

Overview
Journal J Clin Med
Specialty General Medicine
Date 2023 Aug 12
PMID 37568342
Authors
Affiliations
Soon will be listed here.
Abstract

(1) Background: Parathyroid cystic adenomas (PCA) are rare entities representing only 0.5-1% of parathyroid adenomas, accounting for 1-2% of cases of primary hyperparathyroidism (PHPT). The purpose of this study was to compare classical and functional/secreting cystic parathyroid lesions and identify risk factors for severe hypercalcemia; (2) Methods: A total of 17 patients with PHPT and parathyroid cysts (study group) were compared with the group of 100 patients with hyperparathyroidism caused by adenoma or hyperplasia (control group). In both groups the majority were women (88% vs. 12%, with gender ratio 7, 3:1). The patients were examined preoperatively and postoperatively: PTH, creatine, calcium and phosphate serum and urine concentrations and calcidiol serum levels were assessed; (3) Results: Patients with parathyroid cyst had statistically higher PTH and calcium serum concentration, higher calciuria and lower serum phosphate concentration. There were no statistically significant differences in the concentration of creatine in serum and urine and tubular reabsorption of phosphorus (TRP); (4) Conclusions: Due to higher PTH and calcium levels, cystic parathyroid adenomas could be one of the rare risk factors for severe hypercalcemia and hypercalcemic crisis which can be life threatening.

References
1.
McCoy K, Yim J, Zuckerbraun B, Ogilvie J, Peel R, Carty S . Cystic parathyroid lesions: functional and nonfunctional parathyroid cysts. Arch Surg. 2009; 144(1):52-6. DOI: 10.1001/archsurg.2008.531. View

2.
Ahsayen F, Haddadi Z, El Aggari H, Benramdane H, Aichouni N, Nasri S . Dysphagia revealing a giant cystic parathyroid adenoma. Radiol Case Rep. 2022; 17(10):3556-3558. PMC: 9340078. DOI: 10.1016/j.radcr.2022.06.044. View

3.
Mallick R, Chen H . Diagnosis and Management of Hyperparathyroidism. Adv Surg. 2018; 52(1):137-153. DOI: 10.1016/j.yasu.2018.03.006. View

4.
Minisola S, Arnold A, Belaya Z, Brandi M, Clarke B, Hannan F . Epidemiology, Pathophysiology, and Genetics of Primary Hyperparathyroidism. J Bone Miner Res. 2022; 37(11):2315-2329. PMC: 10092691. DOI: 10.1002/jbmr.4665. View

5.
Munoz-Torres M, Garcia-Martin A . Primary hyperparathyroidism. Med Clin (Barc). 2017; 150(6):226-232. DOI: 10.1016/j.medcli.2017.07.020. View